ArticleCureus2023
Tofacitinib Is an Effective Treatment for Refractory Scleromyositis Associated With Anti-PM/Scl.
Jorge Álvarez Troncoso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleCureus2023
Jorge Álvarez Troncoso et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.